We identified the following five anticancer drugs that can most effectively reduce the growth of breast cancer cells with high WHSC1L1 expression: VX-11e, CZC24832, LY2109761, oxaliplatin and erlotinib. The gene discussed is NSD3; the disease is breast cancer.